Rui Yue

Rui Yue

Auto-generated profile, based on publicly available information

Rui Yue

State Key Laboratory of Cardiovascular Diseases and Medical Innovation Center, Shanghai East Hospital, Frontier Science Center for Stem Cell Research, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China.

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2023 in Science China Life Sciences
Verified
Journal Article
Closed access
HBHainan Bao
Hainan Bao
JCJiani Cao
Jiani Cao
MCMengting Chen
Mengting Chen
MCMin Chen
Min Chen
WCWei Chen
Wei Chen
GLGuang-Hui Liu
Guang-Hui Liu

6 April 2023 in Cell Stem Cell
Verified
Journal Article
Closed access
XZXiaoying Zhang
Xiaoying Zhang
DCDandan Cao
Dandan Cao
LXLiting Xu
Liting Xu
YXYanhua Xu
Yanhua Xu
ZGZehua Gao
Zehua Gao
RYRui Yue
Rui Yue

20 January 2021 in Cell Research
Verified
Journal Article
Open access
PDF file
JHJian He
Jian He
JYJing Yan
Jing Yan
JWJianfang Wang
Jianfang Wang
LZLiangyu Zhao
Liangyu Zhao
QXQian Xin
Qian Xin
RYRui Yue
Rui Yue
Human skeletal stem cells (SSCs) have been discovered in fetal and adult long bones. However, the spatiotemporal ontogeny of human embryonic SSCs during early skeletogenesis remains elusive. Here we map the transcriptional landscape of human limb buds and embryonic long bones at single-cell resolution to address this fundamental question. We found remarkable heterogeneity within human limb bud mesenchyme and epithelium, and aligned them along the proximal–distal and anterior–posterior axes using known marker genes. Osteo-chondrogenic progenitors first appeared in the core limb bud mesenchyme, which give rise to multiple populations of stem/progenitor cells in embryonic long bones undergoing endochondral ossification. Importantly, a perichondrial embryonic skeletal stem/progenitor cell (eSSPC) subset was identified, which could self-renew and generate the osteochondral lineage cells, but not adipocytes or hematopoietic stroma. eSSPCs are marked by the adhesion molecule CADM1 and highly enriched with FOXP1/2 transcriptional network. Interestingly, neural crest-derived cells with similar phenotypic markers and transcriptional networks were also found in the sagittal suture of human embryonic calvaria. Taken together, this study revealed the cellular heterogeneity and lineage hierarchy during human embryonic skeletogenesis, and identified distinct skeletal stem/progenitor cells that orchestrate endochondral and intramembranous ossification.

27 December 2021 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
CMChunyang Mo
Chunyang Mo
JGJingxin Guo
Jingxin Guo
JQJiachen Qin
Jiachen Qin
XZXiaoying Zhang
Xiaoying Zhang
YSYuxi Sun
Yuxi Sun
RYRui Yue
Rui Yue

3 March 2023 in Circulation Research
Verified
Journal Article
Closed access
YSYuxi Sun
Yuxi Sun
MMMengqiu Ma
Mengqiu Ma
DCDandan Cao
Dandan Cao
AZAncheng Zheng
Ancheng Zheng
YZYiying Zhang
Yiying Zhang
RYRui Yue
Rui Yue
Background: Myocardial infarction (MI) elicits cardiac fibroblast activation and extracellular matrix (ECM) deposition to maintain the structural integrity of the heart. Recent studies demonstrate that Fap (fibroblast activation protein)—a prolyl-specific serine protease—is an important marker of activated cardiac fibroblasts after MI. Methods: Left ventricle and plasma samples from patients and healthy donors were used to analyze the expression level of FAP and its prognostic value. Echocardiography and histological analysis of heart sections were used to analyze cardiac functions, scar formation, ECM deposition and angiogenesis after MI. RNA-Sequencing, biochemical analysis, cardiac fibroblasts (CFs) and endothelial cells co-culture were used to reveal the molecular and cellular mechanisms by which Fap regulates angiogenesis. Results: We found that Fap is upregulated in patient cardiac fibroblasts after cardiac injuries, while plasma Fap is downregulated and functions as a prognostic marker for cardiac repair. Genetic or pharmacological inhibition of Fap in mice significantly improved cardiac function after MI. Histological and transcriptomic analyses showed that Fap inhibition leads to increased angiogenesis in the peri-infarct zone, which promotes ECM deposition and alignment by cardiac fibroblasts and prevents their overactivation, thereby limiting scar expansion. Mechanistically, we found that BNP (brain natriuretic peptide) is a novel substrate of Fap that mediates postischemic angiogenesis. Fap degrades BNP to inhibit vascular endothelial cell migration and tube formation. Pharmacological inhibition of Fap in Nppb (encoding pre-proBNP) or Npr1 (encoding the BNP receptor)-deficient mice showed no cardioprotective effects, suggesting that BNP is a physiological substrate of Fap. Conclusions: This study identifies Fap as a negative regulator of cardiac repair and a potential drug target to treat MI. Inhibition of Fap stabilizes BNP to promote angiogenesis and cardiac repair.

28 December 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JWJianfang Wang
Jianfang Wang
QZQiaoling Zhu
Qiaoling Zhu
DCDandan Cao
Dandan Cao
QPQiqi Peng
Qiqi Peng
XZXiaoying Zhang
Xiaoying Zhang
RYRui Yue
Rui Yue
Insulin-like growth factor I (IGF-1) is a key regulator of tissue growth and development in response to growth hormone stimulation. In the skeletal system, IGF-1 derived from osteoblasts and chondrocytes are essential for normal bone development; however, whether bone marrow (BM)-resident cells provide distinct sources of IGF-1 in the adult skeleton remains elusive. Here, we show that BM stromal cells (BMSCs) and megakaryocytes/platelets (MKs/PLTs) express the highest levels of IGF-1 in adult long bones. Deletion of Igf1 from BMSCs by Lepr-Cre leads to decreased bone formation, impaired bone regeneration, and increased BM adipogenesis. Importantly, reduction of BMSC-derived IGF-1 contributes to fasting-induced marrow fat accumulation. In contrast, deletion of Igf1 from MKs/PLTs by Pf4-Cre leads to reduced bone formation and regeneration without affecting BM adipogenesis. To our surprise, MKs/PLTs are also an important source of systemic IGF-1. Platelet-rich plasma (PRP) from Pf4-Cre; Igf1 f/f mice showed compromised osteogenic potential both in vivo and in vitro, suggesting that MK/PLT-derived IGF-1 underlies the therapeutic effects of PRP. Taken together, this study identifies BMSCs and MKs/PLTs as two important sources of IGF-1 that coordinate to maintain and regenerate the adult skeleton, highlighting reciprocal regulation between the hematopoietic and skeletal systems.